Effect of transcutaneous electrical nerve stimulation on human blood beta-endorphin levels.
We randomly assigned 42 subjects for treatment with transcutaneous electrical nerve stimulation (TENS) to one of three groups: conventional TENS--80 Hz; low frequency TENS--2 Hz; and a control group--TENS without batteries. Pain threshold measurements and blood beta-endorphin levels were obtained at regular intervals before, during, and for 17 hours after TENS application. We found no significant difference in blood beta-endorphin levels between the groups before, during, or immediately after TENS application. The differences in pain threshold and beta-endorphin levels appeared to be a function of the patient-selection process and not the application of TENS. The results indicated that TENS, with the stimulation characteristics used in this study, did not significantly change the measured plasma levels of beta-endorphin. The blind administration of naloxone hydrochloride, an opiate antagonist, did not significantly alter the perceived experimental pain of these subjects. We could find no evidence that TENS altered experimental pain threshold or plasma beta-endorphin levels.
D000704:Analysis of Variance; D004558:Electric Stimulation; D004599:Electric Stimulation Therapy / Q000379:methods; D004723:Endorphins / Q000097:blood*; D005260:Female; D006801:Humans; D008297:Male; D009270:Naloxone; D010146:Pain / Q000097:blood / Q000209:etiology; D059408:Pain Management; D011863:Radioimmunoassay; D011897:Random Allocation; D013997:Time Factors; D004561:Transcutaneous Electric Nerve Stimulation / Q000379:methods; D001615:beta-Endorphin
D004723:Endorphins; D009270:Naloxone; D001615:beta-Endorphin